The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide ...

LONDON (Reuters) -The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide list price for new medicines is "deeply flawed" and ...

Sandoz has signed a global collaboration agreement with Shanghai Henlius Biotech to commercialize a biosimilar of oncology therapy, ipilimumab (Bristol-Myers Squibb’s Yervoy). The agreement is ...

North Dakota has a new state logo. It was unveiled at the annual Travel Industry Conference in Minot. The logo is described ...

The new launches include the HLX13 (bYervoy), for which Sandoz signed a commercialisation licence deal with Shanghai Henlius Biotech on Tuesday.

Under the terms of the agreement, Sandoz has exclusive commercial rights for a biosimilar of ipilimumab in Australia, Canada, Europe, Japan and the US. The core sequence patent for ipilimumab ...

Richard Saynor, Chief Executive Officer of Sandoz, commented: “With Q1 sales in line with our expectations, we have now delivered fourteen consecutive quarters of top-line growth. This ...

Production begins by year-end, ramping through 2026, alongside a new distinct Tesla Semi logo and support for the powerful V4 Supercharger. Tesla has provided an update to the construction of its ...

Richard Saynor, Chief Executive Officer of Sandoz, commented: "With Q1 sales in line with our expectations, we have now delivered fourteen consecutive quarters of top-line growth. This reconfirms our ...